EULAR 2022: Making the invisible visible in PsA and axSpA 

In this symposium, Prof. Georg Schett, Prof. Denis Poddubnyy, Dr. Raj Sengupta and Prof. Maria-Antonietta D’Agostino discuss:
Impact and associated burden of structural damage progression on patients with PsA and axSpA
Importance of imaging to detect inflammation and tissue damage in PsA and axSpA and allow earlier diagnosis and treatment initiation before structural damage occurs
Benefits of initiating treatment with biologics early in the disease course to potentially improve outcomes and reduce structural damage progression in patients with PsA and axSpA
To watch the Q&A sessions go to 29:50 and 1:05:55.
To watch the session on how to visualize inflammation and tissue response in PsA and axSpA, follow the link: • EULAR 2022: How to vis...
To watch the session on disease modification in axSpA - what does the future hold? Then follow the link: • EULAR 2022: Disease mo...
To learn more about how structural damage progression impacts patients, follow this link: • EULAR 2022: How does s...
Can ultrasound make the invisible visible in PsA? Find out in this shorter video: • EULAR 2022: Can ultras...